Evidence map›Paper›PMID 36220241›Full record

Trial reportClinical medicine (London, England)2022

Predicting outcomes for Crohn's disease using a molecular biomarker: profile trial.

Nurulamin Noor, Biljana Brezina, Juan De La Revilla Negro, Francis Dowling, Simon Bond, Lynne Whitehead, Jacinta Lee, Paul Lyons, Eoin McKinney, Kenneth Smith and 2 more

Abstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Clinical medicine (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Biomarkers That Predict Crohn's Disease Outcomes.Journal of the Canadian Association of Gastroenterology · 2024
    Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nurulamin NoorCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Biljana BrezinaCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Juan De La Revilla NegroCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Francis DowlingCambridge Clinical Trials Unit, Cambridge, UK.
Simon BondCambridge Clinical Trials Unit, Cambridge, UK.
Lynne WhiteheadCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Jacinta LeeUniversity of Cambridge School of Clinical Medicine, Cambridge, UK.
Paul LyonsUniversity of Cambridge School of Clinical Medicine, Cambridge, UK.
Eoin McKinneyUniversity of Cambridge School of Clinical Medicine, Cambridge, UK.
Kenneth SmithUniversity of Cambridge School of Clinical Medicine, Cambridge, UK.
James LeeThe Francis Crick Institute, London, UK.
Miles ParkesCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Crohn DiseaseBiomarkersHumansRemission InductionBiomarkers

Identifiers

PMID36220241
PMCPMC9600841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.